Compare WHWK & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHWK | OPP |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.8M | 198.2M |
| IPO Year | N/A | N/A |
| Metric | WHWK | OPP |
|---|---|---|
| Price | $3.46 | $7.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 160.4K | 92.6K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $7.57 |
| 52 Week High | $4.40 | $8.77 |
| Indicator | WHWK | OPP |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 23.37 |
| Support Level | $1.84 | N/A |
| Resistance Level | $3.77 | $8.03 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 34.85 | 1.25 |
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.